Anixa Biosciences Inc. (NASDAQ: ANIX) stock closed at 3.13 per share at the end of the most recent trading day (a -2.49% change compared to the prior day closing price) with a volume of 48.83K shares and market capitalization of 95.37M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 4 people. Anixa Biosciences Inc. CEO is Amit Kumar.

The one-year performance of Anixa Biosciences Inc. stock is -18.73%, while year-to-date (YTD) performance is 5.39%. ANIX stock has a five-year performance of %. Its 52-week range is between 2.3 and 5.87, which gives ANIX stock a 52-week price range ratio of 23.25%

Anixa Biosciences Inc. currently has a PE ratio of -6.00, a price-to-book (PB) ratio of 2.95, a price-to-sale (PS) ratio of 192.85, a price to cashflow ratio of 18.90, a PEG ratio of 2.32, a ROA of -47.23%, a ROC of -44.76% and a ROE of -48.25%. The company’s profit margin is -%, its EBITDA margin is 3 176 570.00%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Anixa Biosciences Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.13 for the next earnings report. Anixa Biosciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Anixa Biosciences Inc. is Strong Buy (1), with a target price of $11, which is +251.44% compared to the current price. The earnings rating for Anixa Biosciences Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Anixa Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Anixa Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.67, ATR14 : 0.28, CCI20 : -72.77, Chaikin Money Flow : -0.13, MACD : -0.05, Money Flow Index : 45.06, ROC : -9.54, RSI : 44.82, STOCH (14,3) : 12.44, STOCH RSI : 0.18, UO : 46.32, Williams %R : -87.56), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Anixa Biosciences Inc. in the last 12-months were: Amit Kumar (Buy at a value of $130 340), Arnold Baskies (Buy at a value of $160 270), Emily Gottschalk (Buy at a value of $79 457), Lewis H. Titterton (Buy at a value of $451 607), Michael J. Catelani (Buy at a value of $20 978)